• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

X射线照射对阿扑吗啡和左旋多巴在大鼠脑及纹状体中多巴胺水平影响的研究

Influence of x-ray irradiation on the effects of apomorphine and L-dopa with respect to the dopamine level in rat brain and corpus striatum.

作者信息

Markovska V, Georgiev V, Ankov V

出版信息

Acta Physiol Pharmacol Bulg. 1979;5(4):27-34.

PMID:543408
Abstract

The influence of X-ray irradiation on the dopamine level in brain and in corpus striatum of male albino rats is studied. The changes in the influence of the dopaminergic agonists apomorphine and L-DOPA, applied independently and in combination, on the dopamine level in brain and striatum, are established comparatively (in non-irradiated rats and in rats on the 72nd hour after irradiation with 900 R). Apomorphine is found to have no significant influence on the dopamine level in brain and striatum of non-irradiated rats, while L-DOPA and its combination with apomorphine raise this level. On the 72nd hour after irradiation with 900 R there is no essential change in the dopamine level in brain and the striatum; apomorphine raises the dopamine level in brain and striatum; the effect of L-DOPA and its combination with apomorphine is potentiated with respect to the increase of the dopamine level in brain and striatum.

摘要

研究了X射线照射对白化雄性大鼠脑和纹状体中多巴胺水平的影响。比较了多巴胺能激动剂阿扑吗啡和左旋多巴单独及联合应用时,对非照射大鼠以及照射900伦琴后72小时大鼠脑和纹状体中多巴胺水平影响的变化。结果发现,阿扑吗啡对非照射大鼠脑和纹状体中的多巴胺水平无显著影响,而左旋多巴及其与阿扑吗啡联合应用可提高该水平。照射900伦琴后72小时,脑和纹状体中的多巴胺水平无本质变化;阿扑吗啡可提高脑和纹状体中的多巴胺水平;左旋多巴及其与阿扑吗啡联合应用对脑和纹状体中多巴胺水平升高的作用增强。

相似文献

1
Influence of x-ray irradiation on the effects of apomorphine and L-dopa with respect to the dopamine level in rat brain and corpus striatum.X射线照射对阿扑吗啡和左旋多巴在大鼠脑及纹状体中多巴胺水平影响的研究
Acta Physiol Pharmacol Bulg. 1979;5(4):27-34.
2
Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra.左旋多巴对黑质部分和完全损伤大鼠脑内Fos免疫反应性的诱导作用
Exp Neurol. 1993 Apr;120(2):223-32. doi: 10.1006/exnr.1993.1057.
3
Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.抗帕金森病药物布地品对大鼠黑质和纹状体中左旋多巴诱导的多巴胺和5-羟色胺释放影响的微透析研究。
Synapse. 1999 Oct;34(1):36-46. doi: 10.1002/(SICI)1098-2396(199910)34:1<36::AID-SYN5>3.0.CO;2-G.
4
Pentobarbital inhibits L-DOPA-induced dopamine increases in the rat striatum: An in vivo microdialysis study.戊巴比妥抑制大鼠纹状体中左旋多巴诱导的多巴胺增加:一项体内微透析研究。
Brain Res Bull. 2006 May 15;69(5):593-6. doi: 10.1016/j.brainresbull.2006.03.001. Epub 2006 Mar 29.
5
The expression of the calcium binding protein calretinin in the rat striatum: effects of dopamine depletion and L-DOPA treatment.大鼠纹状体中钙结合蛋白钙视网膜蛋白的表达:多巴胺耗竭和左旋多巴治疗的影响。
Exp Neurol. 2000 Aug;164(2):322-32. doi: 10.1006/exnr.2000.7441.
6
Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.帕金森病模型大鼠纹状体和黑质网状部中5-羟色胺能纤维内L-多巴衍生多巴胺的免疫组织化学检测
Neurosci Res. 2007 Sep;59(1):1-7. doi: 10.1016/j.neures.2007.05.002. Epub 2007 May 21.
7
[Antagonism between L-DOPA and apomorphine in their effects on rat behavior].[左旋多巴与阿扑吗啡对大鼠行为影响的拮抗作用]
Biull Eksp Biol Med. 1977 Jul;84(7):51-3.
8
3-O-methyldopa blocks dopa metabolism in rat corpus striatum.3 - O - 甲基多巴可阻断大鼠纹状体中的多巴代谢。
Ann Neurol. 1982 Sep;12(3):267-71. doi: 10.1002/ana.410120310.
9
Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice.小鼠单侧6-羟基多巴胺诱导纹状体损伤后对多巴胺激动剂的超敏反应。
J Pharmacol Exp Ther. 1975 Jan;192(1):42-9.
10
Interaction of bradykinin with dopaminergic receptors in the CNS.缓激肽与中枢神经系统中多巴胺能受体的相互作用。
Pol J Pharmacol Pharm. 1977 May-Jun;29(3):301-11.